Liquefaction in the Prevention of Posterior Capsule Opacification–Safety and Efficacy

Abstract

Purpose: To evaluate the extent of posterior capsule opacification (PCO) following cataract surgery-torsional phacoemulsification with liquefaction method removal of the epithelial cells (right eye), and straight forward torsional phacoemulsification (left eye), with subsequent implantation of the AcrySof SA60AT intraocular lens. Methods: In this prospective clinical trial patients with bilateral cataract were observed. The Evaluation of Posterior Capsule Opacification (EPCO) 2000 software and the Open-Access Systematic Capsule Assessment (OSCA) system were used for PCO assessment at 3, 6, 12 and 24 months after surgery. Postoperative changes in endothelial cell count (ECC) and pachymetry were also evaluated.